• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunotherapy as a Downstaging Therapy for Liver Transplantation.

作者信息

Schwacha-Eipper Birgit, Minciuna Iulia, Banz Vanessa, Dufour Jean François

机构信息

Hepatology, Department of Biomedical Research, University of Bern, Bern, Switzerland.

University Clinic for Visceral Surgery and Medicine, Inselspital, Bern, Switzerland.

出版信息

Hepatology. 2020 Oct;72(4):1488-1490. doi: 10.1002/hep.31234.

DOI:10.1002/hep.31234
PMID:32171041
Abstract
摘要

相似文献

1
Immunotherapy as a Downstaging Therapy for Liver Transplantation.免疫疗法作为肝移植的降期治疗方法。
Hepatology. 2020 Oct;72(4):1488-1490. doi: 10.1002/hep.31234.
2
Downstaging Hepatocellular Carcinoma with Checkpoint Inhibitor Therapy Improves Access to Curative Liver Transplant.免疫检查点抑制剂治疗使肝细胞癌降期，提高了根治性肝移植的机会。
J Gastrointest Cancer. 2024 Jun;55(2):969-974. doi: 10.1007/s12029-024-01040-8. Epub 2024 Mar 14.
3
Morphology of tumor and nontumor tissue in liver resection specimens for hepatocellular carcinoma following nivolumab therapy.纳武利尤单抗治疗后肝细胞癌肝切除标本中肿瘤和非肿瘤组织的形态学。
Mod Pathol. 2021 Apr;34(4):823-833. doi: 10.1038/s41379-020-00679-5. Epub 2020 Sep 28.
4
Combining systemic and local therapies for hepatocellular carcinoma.肝细胞癌的全身治疗与局部治疗联合应用
Lancet Gastroenterol Hepatol. 2021 Dec;6(12):976-978. doi: 10.1016/S2468-1253(21)00388-5. Epub 2021 Oct 23.
5
Immunotherapy as a Downstaging Tool for Liver Transplantation in Hepatocellular Carcinoma.免疫疗法作为肝细胞癌肝移植的降期工具
Am J Gastroenterol. 2021 Dec 1;116(12):2478-2480. doi: 10.14309/ajg.0000000000001391.
6
Hepatocellular carcinoma downstaging for liver transplantation in the era of systemic combined therapy with anti-VEGF/TKI and immunotherapy.系统联合抗血管生成/TKI 和免疫治疗时代的肝癌肝移植降期治疗。
Hepatology. 2022 Oct;76(4):1203-1218. doi: 10.1002/hep.32613. Epub 2022 Jul 30.
7
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference.肝细胞癌的试验设计与终点：美国肝病研究学会共识会议
Hepatology. 2021 Jan;73 Suppl 1:158-191. doi: 10.1002/hep.31327. Epub 2020 Sep 9.
8
Nivolumab induced hyperprogressive disease in advanced esophageal squamous cell carcinoma.纳武单抗在晚期食管鳞状细胞癌中诱发了超进展性疾病。
Cancer Biol Ther. 2020 Dec 1;21(12):1097-1104. doi: 10.1080/15384047.2020.1834319. Epub 2020 Nov 5.
9
Neoadjuvant Radiation Lobectomy and Immunotherapy for Angioinvasive HCC Resulting in Complete Pathologic Response.新辅助放疗、肺叶切除术及免疫疗法治疗血管浸润性肝癌并获得完全病理缓解
Hepatology. 2021 Jul;74(1):525-527. doi: 10.1002/hep.31675. Epub 2021 Apr 27.
10
Immune checkpoint inhibitor for hepatocellular carcinoma recurrence after liver transplantation.用于肝移植后肝细胞癌复发的免疫检查点抑制剂。
Hepatobiliary Pancreat Dis Int. 2020 Feb;19(1):91-93. doi: 10.1016/j.hbpd.2019.09.011. Epub 2019 Oct 25.

引用本文的文献

1
Current knowledge about immunotherapy response after liver transplantation of patients with liver cancer.关于肝癌患者肝移植后免疫治疗反应的当前知识。
J Liver Transpl. 2025 Aug;19. doi: 10.1016/j.liver.2025.100285. Epub 2025 Jun 6.
2
Neoadjuvant immunotherapy for resectable primary liver cancer (Review).可切除原发性肝癌的新辅助免疫治疗（综述）
Oncol Lett. 2025 Jul 23;30(4):458. doi: 10.3892/ol.2025.15204. eCollection 2025 Oct.
3
Liver transplantation in a patient with metastatic hepatocellular carcinoma after downstaging with single-agent immunotherapy: the first case report.
单药免疫治疗降期后转移性肝细胞癌患者的肝移植：首例病例报告
J Gastrointest Oncol. 2025 Jun 30;16(3):1321-1330. doi: 10.21037/jgo-24-764. Epub 2025 Jun 26.
4
Liver transplantation as a new treatment option for perihilar cholangiocarcinoma and colorectal liver metastases: a review.肝移植作为肝门部胆管癌和结直肠癌肝转移的一种新治疗选择：综述
Int J Clin Oncol. 2025 Jul 5. doi: 10.1007/s10147-025-02820-3.
5
Liver resection and transplantation in the era of checkpoint inhibitors.免疫检查点抑制剂时代的肝切除与肝移植
JHEP Rep. 2024 Aug 6;6(11):101181. doi: 10.1016/j.jhepr.2024.101181. eCollection 2024 Nov.
6
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024.2024年亚太肝脏研究学会肝细胞癌全身治疗临床实践指南
Hepatol Int. 2024 Dec;18(6):1661-1683. doi: 10.1007/s12072-024-10732-z. Epub 2024 Nov 21.
7
Immune Checkpoint Inhibitors in the Pre-Transplant Hepatocellular Carcinoma Setting: A Glimpse Beyond the Liver.免疫检查点抑制剂在移植前肝细胞癌治疗中的应用：肝脏之外的探索。
Int J Mol Sci. 2024 Oct 30;25(21):11676. doi: 10.3390/ijms252111676.
8
New Scenarios in Liver Transplantation for Hepatocellular Carcinoma.肝细胞癌肝移植的新情况
Liver Int. 2025 Apr;45(4):e16142. doi: 10.1111/liv.16142. Epub 2024 Nov 4.
9
Liver Transplantation for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors.免疫检查点抑制剂时代肝细胞癌的肝移植
Cancers (Basel). 2024 Jun 28;16(13):2374. doi: 10.3390/cancers16132374.
10
Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis.移植前免疫检查点抑制剂的使用对肝癌移植后结局的影响：一项系统评价和个体患者数据荟萃分析。
J Hepatol. 2025 Jan;82(1):107-119. doi: 10.1016/j.jhep.2024.06.042. Epub 2024 Jul 10.